tisagenlecleucel
novartis
['fil,veral,12', 'elara', 'lymsm', 'lymphoma', 'follicular', 'tisagenlecleucel']
congress | #ash22 martin dreyling, md shares updated long-term data from the elara trial of tisagenlecleucel in r/r #fl. robust responses were sustained &gt;2 years post infusion, with a continued favourable safety profile #lymsm #medicalcongress #hematology 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm